|
EP3491012A1
|
|
Treatment of adult growth hormone deficiency with human growth hormone analogues
|
|
WO2017197048A1
|
|
Albumin binding conjugate compositions and methods of making and using same
|
|
WO2017049205A2
|
|
Growth hormone formulation
|
|
KR20180038560A
|
|
Chimeric polypeptide assemblies and methods for their manufacture and use
|
|
WO2016109823A1
|
|
Treatment of pediatric growth hormone deficiency with human growth hormone analogues
|
|
CN107207564A
|
|
Target XTEN conjugate compositions and preparation method thereof
|
|
US2017095567A1
|
|
Growth hormone polypeptides and methods of making and using same
|
|
AU2015200260A1
|
|
Glucose-regulating polypeptides and methods of making and using same
|
|
AU2014249258A1
|
|
Treatment of pediatric growth hormone deficiency with human growth hormone analogues
|
|
CN104661674A
|
|
Factor VIII complex with XTEN and von willebrand factor protein, and uses thereof
|
|
CN104519903A
|
|
HGH-XTEN fusion protein and use in treatment of growth hormone deficiency
|
|
EP2819788A2
|
|
Xten conjugate compositions and methods of making same
|
|
HK1163245A1
|
|
Unstructured recombinant polymers and uses thereof
|
|
US2013017997A1
|
|
Factor VIII Compositions and Methods of Making and Using Same
|
|
WO2011123830A2
|
|
Alpha 1-antitrypsin compositions and methods of making and using same
|
|
EP3372617A2
|
|
Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using same
|
|
WO2011084808A2
|
|
Bifunctional polypeptide compositions and methods for treatment of metabolic and cardiovascular diseases
|
|
CN102741422A
|
|
Coagulation factor ix compositions and methods of making and using same
|
|
WO2011028344A2
|
|
Interleukin-1 receptor antagonist compositions and methods of making and using same
|
|
AU2010258898A1
|
|
Glucose-regulating polypeptides and methods of making and using same
|
